PENSULVIT SIFI
ItalyIt is used to treat eye infections caused by germs sensitive to its active ingredients, such as conjunctivitis, ulcerative blepharitis, dacryocystitis, and septic corneal ulcers. It can also be used for prevention before and after surgery and as an aid in the treatment of trachoma.
Frequently asked questions
How should Pensulvit be used?
Apply once, three or four times a day, or follow the specific instructions of a physician.
When should you not use this medicine?
It must not be used in case of proven hypersensitivity to the components of the product.
What are the side effects of Pensulvit?
The product is generally well tolerated. If sensitization reactions to the components occur, or if no clinical improvement is observed within a reasonable timeframe, it is necessary to discontinue treatment and consult a physician.
Are there any special precautions for use?
During pregnancy and in early infancy, the product should be used only if strictly necessary and under the direct supervision of a physician. Prolonged use of antibiotics for the eyes may promote the growth of microorganisms that are not sensitive to the drug.
Can the product interact with other medicines?
The product is incompatible with silver-based preparations. Furthermore, sulfonamides may be inactivated by para-aminobenzoic acid (present, for example, in procaine).
Instructions for use
Table of contents
Package leaflet
PENSULVIT 1% + 5%
Ophthalmic ointment
Tetracycline
Sulfamethizole
Composition
100 g contains:
Active substances: Tetracycline 1 g - Sulfamethizole 5 g.
Excipients: Anhydrous lanolin - Cod liver oil - Liquid paraffin -
White vaseline.
Pharmaceutical form and content
Ophthalmic ointment in a 6.5 g tube.
Pharmacotherapeutic category
Pensulvit is a combination of broad-spectrum antibiotics. Therefore, it is active
against microorganisms most frequently responsible for ocular infections.
Marketing Authorization Holder:
S.I.F.I. S.p.A. - Registered office: via Ercole Patti, 36 – 95020 Lavinaio - Aci S.
Antonio (CT)
Manufacturer:
S.I.F.I. S.p.A. - Aci S. Antonio (CT) facility
Therapeutic indications
Ocular infections caused by microorganisms sensitive to Tetracycline and Sulfamethizole,
such as ulcerative blepharitis, dacryocystitis, conjunctivitis, septic corneal ulcers. Pre- and post-operative prophylaxis. Adjunctive treatment in trachoma.
Contraindications
Proven individual hypersensitivity to the drug.
Precautions for use
In early infancy and during pregnancy, the product should be administered only when clearly necessary and under direct medical supervision.
Pharmacological interactions
Sulfonamides are inactivated by para-aminobenzoic acid present in purulent exudates and by its derivatives (procaine).
The sulfonamide-trimethoprim combination exerts a synergistic effect.
The product is incompatible with silver-based preparations.
Special warnings
Prolonged use of topical antibiotics may lead to the overgrowth of microorganisms not sensitive to them.
If no clear clinical improvement occurs within a reasonable time during treatment, or if signs of sensitization to the active components occur, treatment must be discontinued and appropriate therapy initiated.
Dosage, method and duration of administration
Apply once three to four times daily, or as prescribed by a physician.
Undesirable effects
Pensulvit is generally well tolerated.
Patients are advised to inform their physician or pharmacist if any adverse reactions not described in this leaflet occur.
Expiry date
Refer to the packaging for the expiry date.
Caution: do not use the medicine after the expiry date stated on the packaging.
Store below 25 °C.
FOR OPHTHALMIC USE
KEEP MEDICINE OUT OF REACH OF CHILDREN
The original data is available in the language of the country of manufacture.
Data source: Italian Medicines Agency (AIFA)
Data last verified: September 21, 2026